Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoflipid vs Intralipid in Preterm Infants with Sepsis
NCT03275090Phase 4Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of SMOFlipid in sepsis (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoints: soluble intercellular adhesion molecule 1 at Day 7 and Leukocyte integrin beta-2 at Day 7. Started Feb 2016; status: completed.
02
Drugs
SMOFlipid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03275090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275090.